Advertisement
Screener

PALOMINO LABORATORIES INC. (PALX) Proceeds from Issuance or Sale of Equity

PALOMINO LABORATORIES INC. Proceeds from Issuance or Sale of Equity

PALOMINO LABORATORIES INC. (PALX) reported Proceeds from Issuance or Sale of Equity of $14.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-08-05

  • PALOMINO LABORATORIES INC. proceeds from issuance or sale of equity for the quarter ending 2025-12-31 was $9.76M.
  • PALOMINO LABORATORIES INC. proceeds from issuance or sale of equity for the quarter ending 2025-09-30 was $8.02M.
  • PALOMINO LABORATORIES INC. proceeds from issuance or sale of equity for fiscal 2025 was $9.76M.
Period endProceeds from Issuance or Sale of Equity 3 monthProceeds from Issuance or Sale of Equity 6 monthProceeds from Issuance or Sale of Equity 9 monthProceeds from Issuance or Sale of Equity 12 month
2026-06-30$14.82M
10-Q · filed 2026-08-05
2025-12-31$9.76M
10-K · filed 2026-03-31
$17.77M
derived: sum of 2 quarters · filed 2026-03-31
$9.76M
10-K · filed 2026-03-31
2025-09-30$8.02M
10-Q · filed 2025-11-14
$8.02M
10-Q · filed 2025-11-14